XDEA License Requirement for Buprenorphine Claims Removed
Feb 03, 2023
On December 29, 2022, Congress eliminated the “DATA-Waiver Program” with the signing of the Consolidated Appropriations Act of 2023 (the Act), improving access to buprenorphine for those in need.
In a response to the change as part of the Act, MaineCare eliminated the requirement of an X-DEA number to process pharmacy claims for buprenorphine products. Change Healthcare removed the edits related to the data waiver requirements, effective January 27, 2023.
For questions, please call the Change Healthcare Pharmacy Help Desk at 1-888-420-9711 or email them.